Bio-Techne Corporation
(NASDAQ:TECH)

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates in two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sci...

Website: http://www.bio-techne.com

Founded: 1976

Full Time Employees: 2,300

Sector: Healthcare

Industry: Biotechnology

Healthcare

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30

net sales	311,415,000	295,877,000	286,555,000	316,964,000	316,181,000	297,031,000	289,458,000	306,099,000	303,428,000	272,598,000	276,935,000	301,320,000	294,146,000	271,581,000	269,655,000	288,228,000	290,376,000	269,276,000	257,719,000	259,028,000	243,552,000	224,253,000	204,199,000	175,834,000	194,680,000	184,934,000	183,243,000	191,665,000	184,861,000	174,510,000	162,970,000		163,973,000	154,153,000	144,613,000	156,578,000	144,037,000	131,807,000	130,581,000	134,762,000	130,973,000	120,907,000	112,381,000	117,663,000	114,158,000	111,948,000	108,477,000	92,523,000	95,555,000	84,017,000	85,668,000	79,475,000	80,992,000	75,083,000	75,025,000	78,681,000	83,621,000	74,662,000	77,596,000
yoy	-1.51%	-0.39%	-1.00%	3.55%	4.20%	8.96%	4.52%	1.59%	3.16%	0.37%	2.70%	4.54%	1.30%	0.86%	4.63%	11.27%	19.23%	20.08%	26.21%	47.31%	25.10%	21.26%	11.44%	-8.26%	5.31%	5.97%	12.44%		12.74%	13.21%	12.69%		13.84%	16.95%	10.75%	16.19%	9.97%	9.02%	16.19%	14.53%	14.73%	8.00%	3.60%	27.17%	19.47%	33.24%	26.62%	16.42%	17.98%	11.90%	14.19%	1.01%	-3.14%	0.56%	-3.31%
qoq	5.25%	3.25%	-9.59%	0.25%	6.45%	2.62%	-5.44%	0.88%	11.31%	-1.57%	-8.09%	2.44%	8.31%	0.71%	-6.44%	-0.74%	7.84%	4.48%	-0.51%	6.35%	8.61%	9.82%	16.13%	-9.68%	5.27%	0.92%	-4.39%	3.68%	5.93%	7.08%			6.37%	6.60%	-7.64%	8.71%	9.28%	0.94%	-3.10%	2.89%	8.33%	7.59%	-4.49%	3.07%	1.97%	3.20%	17.24%	-3.17%	13.73%	-1.93%	7.79%	-1.87%	7.87%	0.08%	-4.65%	-5.91%	12.00%	-3.78%
cost of sales	103,127,000	104,600,000	98,443,000	118,152,000	101,625,000	103,145,000	106,441,000	102,751,000	98,829,000	96,011,000	91,744,000	96,622,000	91,984,000	88,221,000	90,060,000	87,878,000	88,918,000	85,585,000	86,722,000	83,084,000	75,278,000	73,353,000	66,468,000	62,520,000	64,617,000	63,531,000	64,829,000	63,405,000	60,251,000	61,492,000	55,367,000		53,712,000	52,319,000	46,745,000	45,771,000	49,854,000	46,725,000	46,111,000	45,070,000	40,984,000	39,320,000	36,990,000	38,575,000	34,778,000	36,205,000	35,411,000	28,930,000	27,444,000	25,424,000	24,554,000	20,358,000	19,845,000	19,820,000	19,442,000	19,817,000	20,238,000	19,492,000	19,209,000
gross margin	208,288,000	191,277,000	188,112,000	198,812,000	214,556,000	193,886,000	183,017,000	203,348,000	204,599,000	176,587,000	185,191,000	204,698,000	202,162,000	183,360,000	179,595,000	200,350,000	201,458,000	183,691,000	170,997,000	175,944,000	168,274,000	150,900,000	137,731,000	113,314,000	130,063,000	121,403,000	118,414,000	128,260,000	124,610,000	113,018,000	107,603,000		110,261,000	101,834,000	97,868,000	110,807,000	94,183,000	85,082,000	84,470,000	89,692,000	89,989,000	81,587,000	75,391,000	79,088,000	79,380,000	75,743,000	73,066,000	63,593,000	68,111,000	58,593,000	61,114,000	59,117,000	61,147,000	55,263,000	55,583,000	58,864,000	63,383,000	55,170,000	58,387,000
yoy	-2.92%	-1.35%	2.78%	-2.23%	4.87%	9.80%	-1.17%	-0.66%	1.21%	-3.69%	3.12%	2.17%	0.35%	-0.18%	5.03%	13.87%	19.72%	21.73%	24.15%	55.27%	29.38%	24.30%	16.31%	-11.65%	4.38%	7.42%	10.05%		13.01%	10.98%	9.95%		17.07%	19.69%	15.86%	23.54%	4.66%	4.28%	12.04%	13.41%	13.36%	7.72%	3.18%	24.37%	16.55%	29.27%	19.56%	7.57%	11.39%	6.03%	9.95%	0.43%	-3.53%	0.17%	-4.80%
qoq	8.89%	1.68%	-5.38%	-7.34%	10.66%	5.94%	-10.00%	-0.61%	15.86%	-4.65%	-9.53%	1.25%	10.25%	2.10%	-10.36%	-0.55%	9.67%	7.42%	-2.81%	4.56%	11.51%	9.56%	21.55%	-12.88%	7.13%	2.52%	-7.68%	2.93%	10.26%	5.03%			8.28%	4.05%	-11.68%	17.65%	10.70%	0.72%	-5.82%	-0.33%	10.30%	8.22%	-4.67%	-0.37%	4.80%	3.66%	14.90%	-6.63%	16.24%	-4.13%	3.38%	-3.32%	10.65%	-0.58%	-5.57%	-7.13%	14.89%	-5.51%
gross margin %	66.88%	64.65%	65.65%	62.72%	67.86%	65.27%	63.23%	66.43%	67.43%	64.78%	66.87%	67.93%	68.73%	67.52%	66.60%	69.51%	69.38%	68.22%	66.35%	67.92%	69.09%	67.29%	67.45%	64.44%	66.81%	65.65%	64.62%	66.92%	67.41%	64.76%	66.03%	NaN%	67.24%	66.06%	67.68%	70.77%	65.39%	64.55%	64.69%	66.56%	68.71%	67.48%	67.09%	67.22%	69.54%	67.66%	67.36%	68.73%	71.28%	69.74%	71.34%	74.38%	75.50%	73.60%	74.09%	74.81%	75.80%	73.89%	75.24%	NaN%	NaN%	NaN%	NaN%
operating expenses:
selling, general and administrative	109,338,000	113,691,000	116,213,000	196,640,000	151,269,000	121,451,000	119,161,000	133,536,000	111,840,000	115,667,000	105,331,000	86,754,000	99,238,000	93,010,000	99,375,000	96,629,000	89,269,000	100,693,000	86,175,000	86,641,000	82,596,000	83,116,000	72,598,000	57,225,000	66,318,000	68,030,000	69,010,000	68,737,000	64,968,000	63,603,000	67,051,000		53,285,000	63,775,000	58,289,000	50,418,000	48,107,000	55,655,000	46,263,000	38,037,000	35,217,000	34,585,000	33,040,000	30,474,000	29,089,000	31,137,000	28,701,000	17,103,000	14,666,000	14,926,000	14,021,000	12,118,000	9,982,000	10,956,000	10,328,000	10,360,000	9,899,000	10,651,000	10,773,000
research and development	23,455,000	23,125,000	24,241,000	26,032,000	24,579,000	25,016,000	23,869,000	23,989,000	25,761,000	22,916,000	23,998,000	23,419,000	22,713,000	22,459,000	23,903,000	23,148,000	21,742,000	20,650,000	21,600,000	20,721,000	17,052,000	16,789,000	16,041,000	16,779,000	15,954,000	16,381,000	16,077,000	16,259,000	15,552,000	15,812,000	14,789,000		13,892,000	13,911,000	13,548,000	13,697,000	13,771,000	13,281,000	12,765,000	11,643,000	11,245,000	10,977,000	11,322,000	10,813,000	10,865,000	10,026,000	9,149,000	7,644,000	7,676,000	7,923,000	7,702,000	7,183,000	7,219,000	7,403,000	7,452,000	7,286,000	7,122,000	6,837,000	6,667,000
total operating expenses	132,793,000	136,816,000	140,454,000	222,672,000	175,848,000	146,467,000	143,030,000	157,525,000	137,601,000	138,583,000	129,329,000	110,173,000	121,951,000	115,469,000	123,278,000	119,777,000	111,011,000	121,343,000	107,775,000	107,362,000	99,648,000	99,905,000	88,639,000	74,004,000	82,272,000	84,411,000	85,087,000	84,996,000	80,520,000	79,415,000	81,840,000		67,177,000	77,686,000	71,837,000	64,115,000	61,878,000	68,936,000	59,028,000	49,680,000	46,462,000	45,562,000	44,362,000	41,287,000	39,954,000	41,163,000	37,850,000	24,747,000	22,342,000	22,849,000	21,723,000	19,301,000	17,201,000	18,359,000	17,780,000	17,646,000	17,021,000	17,488,000	17,440,000
operating income	75,495,000	54,461,000	47,658,000	-23,860,000	38,708,000	47,419,000	39,987,000	45,823,000	66,998,000	38,004,000	55,862,000	94,525,000	80,211,000	67,891,000	56,317,000	80,573,000	90,447,000	62,348,000	63,222,000	68,582,000	68,626,000	50,995,000	49,092,000	39,310,000	47,791,000	36,992,000	33,327,000	43,264,000	44,090,000	33,603,000	25,763,000		43,084,000	24,148,000	26,031,000	46,692,000	32,305,000	16,146,000	25,442,000	40,012,000	43,527,000	36,025,000	31,028,000	37,801,000	39,426,000	34,580,000	35,216,000	38,846,000	45,769,000	35,744,000	39,391,000	39,816,000	43,946,000	36,904,000	37,803,000	41,218,000	46,362,000	37,682,000	40,947,000
yoy	95.04%	14.85%	19.18%	-152.07%	-42.23%	24.77%	-28.42%	-51.52%	-16.47%	-44.02%	-0.81%	17.32%	-11.32%	8.89%	-10.92%	17.48%	31.80%	22.26%	28.78%	74.46%	43.60%	37.85%	47.30%	-9.14%	8.39%	10.09%	29.36%		2.33%	39.15%	-1.03%		33.37%	49.56%	2.32%	16.69%	-25.78%	-55.18%	-18.00%	5.85%	10.40%	4.18%	-11.89%	-2.69%	-13.86%	-3.26%	-10.60%	-2.44%	4.15%	-3.14%	4.20%	-3.40%	-5.21%	-2.06%	-7.68%
qoq	38.62%	14.27%	-299.74%	-161.64%	-18.37%	18.59%	-12.74%	-31.61%	76.29%	-31.97%	-40.90%	17.85%	18.15%	20.55%	-30.10%	-10.92%	45.07%	-1.38%	-7.82%	-0.06%	34.57%	3.88%	24.88%	-17.75%	29.19%	11.00%	-22.97%	-1.87%	31.21%	30.43%			78.42%	-7.23%	-44.25%	44.53%	100.08%	-36.54%	-36.41%	-8.08%	20.82%	16.10%	-17.92%	-4.12%	14.01%	-1.81%	-9.34%	-15.13%	28.05%	-9.26%	-1.07%	-9.40%	19.08%	-2.38%	-8.29%	-11.10%	23.03%	-7.97%
operating margin %	24.24%	18.41%	16.63%	-7.53%	12.24%	15.96%	13.81%	14.97%	22.08%	13.94%	20.17%	31.37%	27.27%	25.00%	20.88%	27.95%	31.15%	23.15%	24.53%	26.48%	28.18%	22.74%	24.04%	22.36%	24.55%	20.00%	18.19%	22.57%	23.85%	19.26%	15.81%	NaN%	26.28%	15.66%	18.00%	29.82%	22.43%	12.25%	19.48%	29.69%	33.23%	29.80%	27.61%	32.13%	34.54%	30.89%	32.46%	41.99%	47.90%	42.54%	45.98%	50.10%	54.26%	49.15%	50.39%	52.39%	55.44%	50.47%	52.77%	NaN%	NaN%	NaN%	NaN%
other income	-4,270,000	-3,677,000	333,000	-1,198,250	-434,000	-4,543,000	184,000	-4,208,750	-5,914,000	-4,617,000	-6,304,000	11,481,000	-15,000	-1,462,000	47,399,000	1,579,250	-21,675,000	23,831,000	4,161,000	-6,913,000	-23,272,000	5,373,000	-9,753,000	24,210,750	-970,000	113,334,000	-15,521,000	-3,556,500	5,787,000	-11,836,000	-8,177,000		-18,102,000	-2,417,000	-3,064,000	-1,549,000	-2,275,000	-2,607,000	-1,314,000	-217,500	-1,037,000	-651,000	818,000	1,674,500	-667,000	7,983,000	-618,000
earnings before income taxes	71,225,000	50,784,000	47,991,000	-22,859,000	38,274,000	42,876,000	40,171,000	41,661,000	61,084,000	33,387,000	49,558,000	88,316,000	80,196,000	66,429,000	103,716,000	79,052,000	68,772,000	86,179,000	67,383,000	7,113,000	45,354,000	56,368,000	39,339,000	61,525,000	46,821,000	150,326,000	17,806,000	22,786,000	49,877,000	21,767,000	17,586,000		24,982,000	21,731,000	22,967,000	44,265,000	30,030,000	13,539,000	24,128,000	37,770,000	42,490,000	35,374,000	31,847,000	38,242,000	38,759,000	42,563,000	34,598,000	39,451,000	46,069,000	36,218,000	39,654,000	40,764,000	44,466,000	37,446,000	37,986,000	40,617,000	43,205,000	37,873,000	40,500,000
income taxes	20,178,000	12,775,000	9,806,000	-5,181,000	15,686,000	7,986,000	6,571,000	1,073,000	12,025,000	5,922,000	-1,435,000	12,832,000	9,978,000	16,424,000	13,982,000	17,137,000	8,628,000	14,120,000	-1,598,000	-7,531,000	-48,000	10,224,000	5,944,000	2,680,000	10,389,000	30,704,000	3,408,000				183,000				7,104,000	12,163,000	8,641,000	7,226,000	7,845,000	12,144,000	12,199,000	9,523,000	9,139,000	11,913,000	14,469,000	9,354,000	10,691,000	12,627,000	14,428,000	11,163,000	12,226,000	12,353,000	11,348,000	12,082,000	12,318,000	13,376,000	11,449,000	12,060,000	12,979,000
net earnings	51,047,000	38,009,000	38,185,000	-17,678,000	22,588,000	34,890,000	33,600,000																33,395,000	58,845,000	36,432,000	119,622,000	14,398,000	16,460,000	44,654,000	17,556,000	17,403,000		19,738,000	48,847,000	15,863,000	32,102,000	21,389,000	6,313,000	16,281,000	25,626,000	30,291,000	25,851,000	22,707,000	26,329,000	24,290,000	33,209,000	23,907,000	26,824,000	31,641,000	25,055,000	27,428,000	28,411,000	33,118,000	25,364,000	25,668,000	27,241,000	31,756,000	25,813,000	27,521,000
yoy	125.99%	8.94%	13.65%																				131.94%	257.50%	-18.41%	581.37%	-17.27%		126.23%	-64.06%	9.71%		-7.72%	673.75%	-2.57%	25.27%	-29.39%	-75.58%	-28.30%	-2.67%	24.71%	-22.16%	-5.02%	-1.85%	-23.23%	32.54%	-12.84%	-5.59%	-4.46%	-1.22%	6.86%	4.29%	4.29%	-1.74%	-6.73%
qoq	34.30%	-0.46%	-316.00%	-178.26%	-35.26%	3.84%																	-43.25%	61.52%	-69.54%	730.82%	-12.53%	-63.14%	154.35%	0.88%			-59.59%	207.93%	-50.59%	50.09%	238.81%	-61.22%	-36.47%	-15.40%	17.18%	13.85%	-13.76%	8.39%	-26.86%	38.91%	-10.87%	-15.22%	26.29%	-8.65%	-3.46%	-14.21%	30.57%	-1.18%	-5.77%	-14.22%	23.02%	-6.21%
net income margin %	16.39%	12.85%	13.33%	-5.58%	7.14%	11.75%	11.61%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	16.35%	33.47%	18.71%	64.68%	7.86%	8.59%	24.16%	10.06%	10.68%	NaN%	12.04%	31.69%	10.97%	20.50%	14.85%	4.79%	12.47%	19.02%	23.13%	21.38%	20.21%	22.38%	21.28%	29.66%	22.04%	28.99%	33.11%	29.82%	32.02%	35.75%	40.89%	33.78%	34.21%	34.62%	37.98%	34.57%	35.47%	NaN%	NaN%	NaN%	NaN%
other comprehensive income:
foreign currency translation income	-4,352,000	2,762,000	-2,850,000	22,953,000	5,311,000	-25,518,000	21,256,000	-1,934,000	-11,981,000	18,025,000
unrealized gains on derivative instruments	-160,000	-711,000	-1,665,000
other comprehensive income	-4,512,000	2,051,000	-4,515,000	22,172,000	3,598,000	-25,563,000	18,229,000	-3,009,000	-11,646,000	14,355,000	-11,952,000	7,487,000	1,574,000	16,685,000	-16,643,000	-20,151,000	4,328,000	4,808,000	-6,964,000	6,821,000	146,000	18,987,000	14,057,000	6,258,000	-25,105,000	13,275,000	-8,106,000	-3,887,000	3,378,000	-12,379,000	-1,136,000		40,956,000	-7,058,000	-824,000	16,359,000	1,925,000	-3,288,000	6,480,000	6,055,000	-24,953,000	2,088,000		11,029,000	-17,145,000	-1,498,000		-1,479,000	6,044,000	4,368,000		1,716,000	2,587,000
comprehensive income	46,535,000	40,060,000	33,670,000	4,494,000	26,186,000	9,327,000	51,829,000																47,452,000	65,103,000	11,327,000	132,897,000	6,292,000	12,573,000	48,032,000	5,177,000	16,267,000		60,694,000	41,789,000	15,039,000	48,461,000	23,314,000	3,025,000	22,761,000	31,681,000	5,338,000	27,939,000	-314,000	37,358,000	7,145,000	31,711,000	6,316,000	25,345,000	37,685,000	29,423,000	-1,446,000	30,127,000	35,705,000	23,473,000	16,034,000
earnings per share:
basic	0.33	0.24	0.25	-0.11	0.14	0.22	0.21	0.26	0.31	0.17	0.32	0.47	0.45	0.32	2.28	1.57	1.55	2.04	1.78	0.38	1.18	1.2	0.87	1.54	0.95	3.13	0.38	0.43	1.18	0.46	0.46		0.53	1.3	0.42	0.86	0.57	0.17	0.44	0.69	0.81	0.7	0.61	0.7	0.65	0.9	0.65	0.73	0.86	0.68	0.74	0.78	0.9	0.69	0.7	0.74	0.86	0.7	0.74
diluted	0.32	0.24	0.24	-0.11	0.14	0.22	0.21	0.26	0.31	0.17	0.31	0.46	0.43	0.31	2.21	1.51	1.48	1.94	1.69	0.36	1.12	1.15	0.83	1.49	0.92	3.02	0.37	0.42	1.15	0.45	0.45		0.52	1.29	0.42	0.86	0.57	0.17	0.43	0.69	0.81	0.69	0.61	0.7	0.65	0.89	0.64	0.73	0.85	0.68	0.74	0.77	0.9	0.69	0.7	0.74	0.86	0.7	0.74
weighted-average common shares outstanding:
basic	156,327	155,839	155,464	157,521	157,372	158,431	158,531	157,708	157,309	157,533	158,130	157,179	157,311	157,011	39,232	39,219	39,272	39,310	39,094	38,747	38,856	38,691	38,536	38,201	38,303	38,167	38,032	37,781	37,772	37,766	37,697	37,476	37,503		37,376	37,313	37,320	37,308	37,281	37,194	37,196	37,189	37,169	37,096	37,138	37,085	37,007	36,890	36,911	36,882	36,842	36,836	36,842	36,834	36,828	36,939	36,864	36,966	37,095	37,098
diluted	157,403	156,999	156,362	159,717	158,944	160,626	161,115	160,774	160,496	160,060	161,940	161,855	161,615	161,750	40,543	41,029	40,969	41,207	41,158	40,483	40,676	40,257	40,025	39,401	39,435	39,550	39,253	38,892	38,861	38,748	38,813	38,055	38,142		37,705	37,500	37,494	37,478	37,473	37,326	37,299	37,301	37,315	37,231	37,269	37,211	37,148	37,005	37,053	37,015	36,928	36,900	36,908	36,900	36,895	37,006	36,930	37,028	37,170	37,172
unrealized gains on derivative instruments - cash flow hedges, net of tax				-781,000	-1,713,000
unrealized gains on derivative instruments - cash flow hedges, net of tax amounts disclosed in note 8						-45,000	-3,027,000	-1,075,000	335,000	-3,670,000	-350,000	2,491,000	-1,708,000	-685,000	4,695,000	2,517,000	7,179,000	2,884,000	1,682,000
net earnings, including noncontrolling interest								40,588,000	49,059,000	27,465,000	50,993,000	75,484,000	70,218,000	50,005,000	89,734,000	61,915,000	60,144,000	72,059,000	68,981,000	14,644,000	45,402,000	46,144,000
net earnings attributable to noncontrolling interest															179,000	391,000	-595,000	-8,114,000	-634,000	-316,000	-380,000	-130,000
net earnings attributable to bio-techne								40,588,000	49,059,000	27,465,000	50,993,000	75,484,000	70,218,000	50,005,000	89,555,000	61,524,000	60,739,000	80,173,000	69,615,000	14,960,000	45,782,000	46,274,000
foreign currency translation reclassified to earnings with eminence deconsolidation															119,000
other comprehensive income attributable to noncontrolling interest															-33,000	-96,000	-1,000	66,000	-39,000	89,000	-69,000	83,000
other comprehensive income attributable to bio-techne								-3,009,000	-11,646,000	14,355,000	-11,952,000	7,487,000	1,574,000	16,685,000	-16,610,000	-20,055,000	4,329,000	4,742,000	-6,925,000	8,294,000	215,000	18,904,000
comprehensive income attributable to bio-techne								37,579,000	37,413,000	41,820,000	39,041,000	82,971,000	71,792,000	66,690,000	72,945,000	41,469,000	65,068,000	84,915,000	62,690,000	21,692,000	45,997,000	65,178,000
earnings per share attributable to bio-techne:
basic	0.33	0.24	0.25	-0.11	0.14	0.22	0.21	0.26	0.31	0.17	0.32	0.47	0.45	0.32	2.28	1.57	1.55	2.04	1.78	0.38	1.18	1.2	0.87	1.54	0.95	3.13	0.38	0.43	1.18	0.46	0.46		0.53	1.3	0.42	0.86	0.57	0.17	0.44	0.69	0.81	0.7	0.61	0.7	0.65	0.9	0.65	0.73	0.86	0.68	0.74	0.78	0.9	0.69	0.7	0.74	0.86	0.7	0.74
diluted	0.32	0.24	0.24	-0.11	0.14	0.22	0.21	0.26	0.31	0.17	0.31	0.46	0.43	0.31	2.21	1.51	1.48	1.94	1.69	0.36	1.12	1.15	0.83	1.49	0.92	3.02	0.37	0.42	1.15	0.45	0.45		0.52	1.29	0.42	0.86	0.57	0.17	0.43	0.69	0.81	0.69	0.61	0.7	0.65	0.89	0.64	0.73	0.85	0.68	0.74	0.77	0.9	0.69	0.7	0.74	0.86	0.7	0.74
foreign currency translation adjustments											-11,602,000	4,996,000	3,282,000	17,370,000	-21,457,000	-22,668,000	-2,851,000	1,924,000	-8,646,000	5,251,000	-1,142,000	16,928,000	11,914,000	5,175,000	-19,403,000	11,867,000	-7,602,000			-8,464,000	-1,136,000		2,297,000	1,524,000	6,968,000	7,838,000	2,400,000	-10,066,000	-3,234,000	-6,670,000	7,128,000	-7,514,000	-12,896,000	8,521,000	-20,094,000	-15,837,000	-9,103,000	3,840,000	733,000	3,344,000	7,902,000	694,000	-9,264,000	1,107,000	3,925,000
derivative instruments - cash flow hedges																				1,372,500	1,288,000	2,059,000	2,143,000	-1,199,500	-5,702,000	1,408,000
unrealized gains on derivative instruments - cash flow hedges, net of tax of 154 in fy20																											-504,000
income tax expense																												2,404,250	5,223,000	4,211,000			5,244,000	-27,116,000
foreign currency translation gain																												-1,092,000	5,232,000
unrealized gain on derivative instruments - cash flow hedges																												-1,442,250	-1,854,000	-3,915,000
unrealized gain on available-for-sale investments
cash dividends per common share:																												0.24	0.32	0.32	0.32		0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.31	0.32	0.31	0.31	0.3	0.3	0.3	0.3	0.28	0.28	0.28	0.28	0.27
unrealized gains and losses on available-for-sale investments
unrealized gain on available-for-sale investments, net of tax of (10,120), 293, (4,745), and (1,767), respectively																																	38,659,000
unrealized gain on available-for-sale investments, net of tax of 799, (1,889), 5,375, and (2,060), respectively																																		-8,582,000
weighted average common shares outstanding:
basic																																		37,449
diluted																																		37,926
unrealized gains and losses on available-for-sale investments, net of tax of 4,576 and (171), respectively																																			-7,792,000
unrealized gain on available-for-sale investments, net of tax of 293, 3,611, (1,767), and 3,917, respectively																																				4,002,500	-475,000
unrealized gain on available-for-sale investments, net of tax of (1,889), (3,466), (2,060), and 306, respectively																																						6,778,000
unrealized gains and losses on available-for-sale investments, net of tax of (171) and 3,752, respectively																																							9,714,000
unrealized gain on available-for-sale investments, net of tax of (3,611), 1,644, (3,917) and 2,070, respectively																																								-8,151,250	-32,081,000
unrealized gain on available-for-sale investments, net of tax of 3,466, 526, (306) and 426, respectively																																										9,602,000
unrealized losses on available-for-sale investments, net of tax of (3,752) and (100), respectively																																											-10,125,000
other comprehensive loss																																											-23,021,000				-17,591,000				-28,874,000			-1,891,000	-9,634,000
unrealized gain on available-for-sale investments, net of tax of 1,644, 42, 2,070 and (16,887), respectively																																												2,200,000	2,949,000
unrealized gain on available-for-sale investments, net of tax of 526, 467, 426 and (16,929), respectively																																														14,339,000
unrealized losses on available-for-sale investments, net of tax of (100) and (17,396), respectively																																															-8,488,000
other income:
interest income																																																1,043,000	529,000	545,000	567,000	670,000	638,000	677,000	661,000	643,000	470,000	798,000	728,000
other non-operating expense																																																-438,000	-229,000	-71,000	-304,000	278,000	-118,000	-135,000	-478,000	-1,244,000	-373,000	-607,000	-1,175,000
total other income																																																605,000	300,000	474,000	263,000	948,000	520,000	542,000	183,000	-601,000	-3,157,000	191,000	-447,000
unrealized gains on available-for-sale investments, net of tax of 42, 6,610, (16,887) and (2,659), respectively																																																-7,610,250	5,311,000
unrealized gains on available-for-sale investments, net of tax of 467, (1,680), (16,929) and (9,269), respectively																																																		1,024,000
unrealized losses on available-for-sale investments, net of tax of (17,396) and (7,589), respectively																																																			-36,776,000
impairment losses on investments																																																									-3,254,000
unrealized gains on available-for-sale investments, net of tax of 6,610, 13,326, (2,659) and 13,319, respectively																																																				-1,176,500	11,851,000
unrealized gains on available-for-sale investments, net of tax of (1,680), 11, (9,269) and (7), respectively																																																						-2,998,000
unrealized gains on available-for-sale investments, net of tax of (7,589) and (18), respectively																																																							-13,559,000

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30

assets
current assets:
cash and cash equivalents	209,819,000	172,879,000	144,962,000	162,186,000	140,670,000	177,549,000	187,540,000	151,791,000	139,915,000	130,132,000	148,663,000	180,571,000	127,282,000	164,682,000	165,257,000	172,567,000	160,821,000	211,845,000	196,321,000	199,091,000	186,136,000	165,526,000	169,404,000	146,625,000	156,216,000	110,293,000	99,891,000	100,886,000	95,561,000	85,886,000	94,674,000	121,990,000	86,608,000	121,458,000	72,464,000	91,612,000	59,840,000	58,936,000	69,589,000	64,237,000	65,713,000	62,452,000	48,842,000	54,532,000	106,447,000	92,968,000	98,239,000	318,568,000	123,603,000	98,402,000	83,856,000	163,786,000	150,713,000	143,286,000	130,805,000	116,675,000	95,280,000	80,994,000	79,235,000	77,613,000
accounts receivable, less allowances	214,562,000	184,614,000	183,897,000	206,876,000	237,140,000
inventories	201,175,000	205,447,000	203,188,000	189,446,000	191,083,000	188,373,000	185,041,000	179,731,000	179,496,000	180,839,000	186,080,000	171,638,000	169,464,000	160,233,000	150,009,000	141,123,000	128,283,000	121,858,000	117,366,000	116,748,000	109,990,000	106,590,000	106,003,000	103,152,000	99,673,000	95,351,000	90,855,000	91,050,000	93,839,000	90,905,000	90,918,000	85,648,000	88,586,000	68,280,000	66,532,000	60,151,000	63,767,000	66,089,000	70,519,000	57,102,000	57,066,000	58,675,000	58,967,000	49,577,000	51,045,000	52,815,000	52,195,000	38,847,000	38,386,000	39,992,000	39,957,000	34,877,000	35,675,000	37,600,000	38,397,000	38,277,000	40,497,000	40,978,000	42,116,000	44,906,000
current assets held-for-sale				12,332,000	4,700,000	1,047,000	9,459,000	9,773,000	26,669,000	26,647,000
other current assets	62,494,000	74,492,000	77,460,000	37,460,000	53,647,000	49,731,000	42,839,000	33,658,000	31,286,000	40,051,000	52,164,000	27,066,000	27,920,000	23,431,000	24,773,000	22,856,000	31,558,000	36,496,000	43,773,000	16,919,000	22,582,000	24,148,000	25,865,000	24,341,000	13,715,000	14,020,000	19,955,000	18,058,000	16,877,000	19,213,000	13,720,000	10,668,000				13,330,000				7,561,000				6,240,000
total current assets	688,050,000	637,432,000	609,507,000	608,300,000	627,240,000	634,640,000	648,567,000	617,419,000	610,650,000	590,640,000	591,477,000	621,482,000	570,996,000	565,183,000	552,031,000	605,556,000	593,108,000	590,230,000	543,748,000	510,606,000	566,606,000	541,933,000	541,893,000	520,920,000	491,928,000	465,074,000	391,945,000	412,607,000	423,433,000	379,934,000	383,112,000	398,366,000	393,504,000	346,086,000	307,158,000	348,025,000	306,042,000	294,106,000	310,151,000	253,891,000	236,739,000	258,383,000	240,997,000	248,283,000	294,738,000	273,530,000	268,111,000	469,413,000	319,531,000	279,141,000	280,636,000	409,516,000	390,157,000	359,731,000	350,143,000	346,507,000	306,272,000	227,216,000	219,010,000	230,417,000
property and equipment	232,990,000	234,383,000	240,334,000	245,719,000	251,977,000	249,753,000	253,939,000	251,154,000	243,728,000	234,204,000	231,683,000	226,200,000	223,571,000	223,851,000	224,098,000	223,242,000	218,398,000	211,814,000	207,134,000	207,907,000	198,975,000	195,602,000	191,677,000	176,829,000	165,012,000	164,313,000	156,783,000	154,039,000	145,319,000	145,262,000	146,511,000	145,348,000	142,779,000	138,461,000	136,846,000	135,124,000	132,146,000	131,952,000	133,805,000	132,362,000	133,666,000	134,043,000	132,852,000	129,749,000	124,485,000	124,776,000	122,006,000	117,120,000	116,649,000	115,159,000	113,362,000	108,756,000	105,202,000	101,133,000	94,920,000	93,788,000	94,614,000	94,604,000	94,352,000	95,398,000
right-of-use assets	68,316,000	68,249,000	70,725,000	73,399,000	83,744,000	85,383,000	89,221,000	91,285,000	97,258,000	100,863,000
goodwill	977,800,000	980,561,000	978,912,000	980,935,000	968,612,000	964,607,000	982,585,000	972,663,000	970,966,000	980,082,000	969,376,000	872,737,000	870,542,000	869,589,000	865,418,000	822,101,000	827,618,000	832,056,000	840,020,000	843,067,000	746,460,000	746,666,000	731,636,000	728,308,000	725,831,000	734,241,000	730,412,000	732,667,000	719,608,000	706,355,000	704,790,000	597,890,000	610,667,000	589,101,000	587,780,000	579,026,000	569,738,000	557,731,000	565,789,000	430,882,000	434,734,000	423,895,000	427,317,000	390,638,000	385,831,000	401,651,000	305,234,000	151,473,000	144,654,000	144,361,000	143,800,000	84,336,000	84,311,000	87,166,000	86,936,000	85,682,000	86,524,000	85,240,000	85,360,000	86,633,000
intangible assets	319,074,000	334,990,000	350,107,000	365,599,000	443,699,000	461,051,000	486,004,000	507,081,000	526,428,000	550,605,000	578,971,000	534,645,000	553,257,000	567,647,000	585,534,000	531,522,000	551,342,000	569,347,000	596,300,000	615,968,000	489,178,000	504,172,000	507,591,000	516,545,000	530,333,000	549,712,000	563,338,000	579,429,000	579,142,000	608,273,000	632,686,000	446,332,000	443,794,000	438,360,000	451,024,000	452,042,000	482,693,000	493,542,000	503,626,000	310,524,000	315,310,000	315,547,000	325,396,000	292,839,000	297,313,000	313,255,000	307,508,000	108,776,000	96,110,000	98,546,000	100,523,000	40,552,000	41,779,000	44,938,000	46,073,000	46,476,000	48,352,000	48,679,000	50,030,000	52,282,000
other assets	264,371,000	267,084,000	276,563,000	273,609,000	268,987,000	274,990,000	275,701,000	264,265,000	272,140,000	274,359,000	281,576,000	285,302,000	283,354,000	53,194,000	53,895,000	46,828,000	45,976,000	37,106,000	11,589,000	11,575,000	11,593,000	11,339,000	10,281,000	13,522,000	12,167,000	9,251,000	5,588,000	5,668,000	5,116,000	5,008,000	5,099,000	5,266,000	27,064,000	43,414,000	44,572,000	44,002,000	42,812,000	42,694,000	4,106,000	1,922,000	1,474,000	1,585,000	1,757,000	1,851,000	1,938,000	1,701,000	1,826,000	1,688,000	2,265,000	2,368,000	2,492,000	2,031,000	3,076,000	3,033,000	2,844,000	1,849,000	1,621,000	1,219,000	11,300,000	1,319,000
total assets	2,550,601,000	2,522,699,000	2,526,148,000	2,557,868,000	2,644,259,000	2,670,424,000	2,736,017,000	2,703,867,000	2,721,170,000	2,730,753,000	2,755,360,000	2,638,692,000	2,599,696,000	2,363,401,000	2,350,721,000	2,294,805,000	2,299,892,000	2,304,846,000	2,270,187,000	2,262,957,000	2,084,642,000	2,067,866,000	2,053,096,000	2,027,589,000	1,999,022,000	1,998,415,000	1,925,028,000	1,884,410,000	1,872,618,000	1,844,832,000	1,872,198,000	1,593,202,000	1,617,808,000	1,555,422,000	1,527,380,000	1,558,219,000	1,533,431,000	1,520,025,000			1,121,924,000	1,133,453,000
liabilities and shareholders’ equity
current liabilities:
trade accounts payable	23,490,000	26,269,000	30,157,000	25,311,000	31,644,000	33,120,000	31,559,000	37,968,000	28,895,000	31,514,000	28,084,000	25,679,000	27,120,000	24,100,000	30,475,000	33,865,000	30,859,000	26,756,000	25,621,000	29,384,000	25,842,000	24,252,000	27,190,000	23,090,000	19,735,000	19,092,000	14,106,000	16,210,000	14,898,000	16,013,000	18,259,000	18,452,000	14,530,000	11,318,000	15,082,000	16,856,000	12,034,000	12,908,000	14,178,000	20,653,000	13,516,000	10,426,000	13,177,000	13,443,000	13,510,000	13,127,000	13,571,000	9,652,000	8,418,000	7,163,000	6,656,000	6,236,000	6,189,000	6,466,000	6,541,000	6,291,000	6,451,000	5,914,000	5,734,000	5,207,000
salaries, wages and related accruals	54,429,000	45,026,000	43,599,000	65,791,000	61,896,000	53,594,000	41,977,000	49,818,000	44,313,000	32,995,000	34,891,000	36,747,000	38,518,000	28,633,000	32,557,000	61,953,000	55,642,000	43,921,000	32,213,000	51,294,000	43,268,000	31,907,000	21,805,000	31,087,000	23,426,000	18,612,000	17,543,000	28,638,000	23,523,000	19,677,000	15,180,000	23,710,000	19,839,000	26,537,000	22,740,000	26,602,000	16,886,000	15,610,000	10,110,000	14,868,000	13,100,000	10,130,000	9,134,000	10,344,000	9,281,000	9,007,000	9,869,000	6,158,000	6,462,000	5,174,000	6,409,000	4,025,000	4,610,000	3,611,000	4,536,000	4,699,000	5,377,000	3,764,000	4,864,000	4,784,000
accrued expenses	17,682,000	20,337,000	19,179,000	25,663,000	23,905,000	27,543,000	21,088,000	24,886,000	17,806,000	17,159,000	15,937,000	14,880,000	15,641,000	16,279,000	13,790,000	17,886,000	19,998,000	18,991,000	17,419,000	15,282,000	15,689,000	13,973,000	13,004,000	9,093,000	9,696,000	10,736,000	11,048,000	26,389,000	28,296,000	25,862,000	23,509,000	21,403,000	18,767,000	14,508,000	19,435,000	18,518,000	23,430,000	19,861,000	19,967,000	8,371,000	7,021,000	7,493,000	6,537,000	6,604,000	7,208,000	9,351,000	6,709,000	4,136,000	3,806,000	7,954,000	4,242,000	9,603,000	7,438,000	4,693,000	3,101,000	7,275,000	10,152,000	3,478,000	11,680,000
contract liabilities	38,433,000	31,030,000	30,445,000	32,571,000	32,269,000	27,715,000	26,614,000	27,930,000	30,108,000	28,427,000	24,516,000	23,069,000	24,878,000	21,812,000	22,059,000	23,406,000	23,107,000	19,081,000	19,121,000	18,995,000	18,714,000	13,217,000	13,285,000	13,049,000	13,556,000	11,893,000	9,108,000	9,084,000	10,112,000	8,396,000	8,762,000
income taxes payable	2,971,000	2,476,000	2,848,000	10,770,000	3,628,000	3,141,000	3,136,000	3,706,000	12,082,000	6,646,000	5,938,000	12,022,000	18,168,000	25,277,000	17,270,000	13,237,000	9,788,000	14,284,000	6,505,000	5,336,000	3,562,000	3,658,000	2,157,000	2,376,000	10,378,000	12,851,000	6,533,000	5,764,000	5,318,000	4,984,000	5,232,000	8,878,000	6,412,000	-7,372,000	3,500,000	2,478,000	1,920,000		4,646,000	1,779,000	3,953,000	852,000	8,444,000	1,972,000	2,019,000	4,001,000	1,975,000	496,000	5,678,000	1,818,000	2,969,000	2,276,000	4,176,000	2,284,000	2,553,000	3,251,000	4,477,000	967,000	3,958,000	5,509,000
operating lease liabilities - current	14,181,000	13,710,000	13,771,000	14,098,000	14,049,000	13,511,000	13,485,000	12,920,000	12,978,000	12,672,000	12,198,000	11,199,000	10,723,000	10,975,000	12,115,000	11,928,000	11,864,000	11,809,000	12,001,000	11,602,000	10,414,000	9,912,000	9,695,000	9,535,000	9,544,000	9,398,000	9,260,000
other current liabilities	2,092,000	1,578,000	4,546,000	1,645,000	1,813,000	2,632,000	4,269,000	2,151,000	2,949,000	4,225,000	4,440,000	1,413,000	865,000	1,319,000	1,963,000	1,243,000	3,080,000	5,467,000	3,612,000	3,891,000	2,581,000	3,166,000
total current liabilities	153,278,000	140,426,000	144,545,000	175,849,000	169,204,000	161,256,000	142,128,000	159,379,000	149,820,000	135,231,000	127,754,000	128,509,000	141,163,000	128,395,000	137,629,000	176,018,000	166,838,000	154,809,000	133,992,000	152,284,000	137,640,000	117,568,000	105,424,000	106,668,000	104,985,000	104,953,000	88,268,000	101,985,000	98,047,000	87,432,000	83,442,000	79,510,000	70,889,000	111,679,000	107,031,000	135,522,000	142,200,000	120,326,000	107,016,000	54,147,000	46,616,000	35,829,000	45,040,000	39,768,000	38,513,000	44,280,000	40,618,000	26,391,000	24,364,000	22,109,000	20,276,000	32,084,000	32,481,000	21,268,000	22,901,000	35,750,000	30,721,000	14,123,000	26,236,000	18,188,000
deferred income taxes	14,210,000	11,021,000	11,273,000	6,169,000	31,924,000	37,723,000	50,017,000	55,863,000	63,666,000	71,575,000	83,134,000	88,982,000	94,607,000	111,381,000	112,920,000	98,994,000	99,301,000	101,423,000	98,812,000	93,125,000	98,401,000	105,342,000	101,374,000	101,090,000	96,178,000	104,579,000	88,530,000	89,754,000	96,844,000	104,113,000	113,843,000	86,293,000	86,987,000	74,103,000	116,784,000	120,596,000	132,072,000	133,239,000	135,512,000	62,837,000	61,373,000	11,513,000	16,677,000	11,511,000	11,729,000	13,090,000	19,148,000	9,623,000	8,509,000	9,878,000	9,527,000	9,944,000	10,068,000	4,214,000	6,170,000	14,234,000	4,264,000	12,921,000	6,730,000	5,797,000
long-term debt obligations	200,000,000	260,000,000	300,000,000	346,000,000	330,000,000	300,000,000	300,000,000	319,000,000	389,000,000	447,000,000	440,000,000	350,000,000	370,000,000	200,000,000	264,661,000	243,410,000	246,514,000	269,618,000	287,723,000	328,827,000	202,931,000	219,035,000	311,139,000	344,243,000	407,348,000	370,452,000	473,556,000	492,660,000				339,000,000	392,500,000	362,500,000	337,500,000	343,771,000	343,637,000	343,659,000	343,500,000	91,500,000	157,808,000	162,789,000	164,368,000	73,000,000	144,000,000	144,000,000	112,000,000
operating lease liabilities	76,141,000	77,185,000	80,702,000	83,960,000	79,450,000	81,616,000	85,433,000	87,618,000	92,752,000	96,027,000	97,332,000	93,766,000	93,267,000	78,183,000	64,756,000	58,133,000	56,348,000	57,718,000	65,059,000	67,625,000	66,816,000	63,672,000	65,694,000	67,248,000	69,491,000	71,693,000	72,870,000
other long-term liabilities	21,668,000	23,078,000	23,814,000	27,082,000	15,656,000	11,337,000	19,789,000	13,157,000	11,557,000	17,361,000	9,394,000	10,919,000	10,973,000	11,336,000	11,501,000	12,239,000	12,769,000	11,747,000	20,046,000	24,462,000	23,812,000	25,796,000	29,981,000	26,949,000	28,052,000	20,706,000	22,450,000	25,222,000	19,496,000	17,993,000	9,671,000	9,338,000	9,140,000	9,321,000	6,255,000	5,403,000	4,397,000	3,628,000	3,654,000	3,317,000	3,164,000	3,220,000	3,146,000	3,204,000	2,144,000	1,896,000	708,000
shareholders’ equity:
undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding
common stock	1,565,000	1,559,000	1,557,000	1,550,000	1,568,000	1,579,000	1,589,000	1,582,000	1,576,000	1,571,000	1,584,000	1,576,000	1,573,000	1,571,000	392,000	392,000	393,000	393,000	393,000	390,000	389,000	388,000	386,000	385,000	381,000	383,000	381,000	379,000	378,000	377,000	378,000	376,000	375,000	375,000	374,000	374,000	373,000	373,000	373,000	372,000	372,000	372,000	372,000	371,000	372,000	371,000	370,000	370,000	369,000	369,000	369,000	368,000	368,000	368,000	368,000	368,000	369,000	369,000	370,000	371,000
additional paid-in capital	1,005,403,000	964,955,000	946,118,000	911,089,000	902,124,000	875,864,000	855,973,000	820,337,000	790,418,000	764,273,000	746,606,000	721,543,000	715,052,000	700,684,000	680,057,000	653,657,000	636,321,000	616,429,000	583,851,000	534,411,000	514,299,000	481,004,000	448,679,000	420,536,000	381,632,000	362,534,000	334,112,000	316,797,000	297,748,000	283,854,000	274,584,000	246,568,000	226,469,000	214,697,000	206,761,000	199,161,000	194,010,000	188,415,000	184,213,000	178,760,000	172,144,000	168,960,000	166,603,000	163,306,000	161,850,000	157,728,000	150,308,000	147,004,000	142,658,000	140,390,000	136,613,000	134,895,000	134,118,000	133,827,000	132,291,000	131,851,000	131,417,000	130,517,000	129,653,000	129,312,000
retained earnings	1,145,192,000	1,106,819,000	1,082,534,000	1,066,049,000	1,196,385,000	1,286,699,000	1,341,175,000	1,325,247,000	1,297,688,000	1,261,376,000	1,327,572,000	1,309,461,000	1,246,612,000	1,199,976,000	1,162,515,000	1,122,921,000	1,132,807,000	1,145,641,000	1,119,337,000	1,085,461,000	1,088,788,000	1,104,762,000	1,073,362,000	1,057,470,000	1,012,713,000	1,038,783,000	931,358,000	931,934,000	927,773,000	895,205,000	905,139,000	876,931,000	847,310,000	839,564,000	802,434,000	799,027,000	778,836,000	769,005,000	774,734,000	770,553,000	756,926,000	738,538,000	724,586,000	713,851,000	699,466,000	687,060,000	665,714,000	653,279,000	637,923,000	617,722,000	604,102,000	587,725,000	572,186,000	550,120,000	535,805,000	520,448,000	505,834,000	487,524,000	479,551,000	472,730,000
accumulated other comprehensive loss	-66,856,000	-62,344,000	-64,395,000	-59,880,000	-82,052,000	-85,650,000	-60,087,000	-78,316,000	-75,307,000	-63,661,000	-78,016,000	-66,064,000	-73,551,000	-75,125,000	-91,810,000	-75,200,000	-55,145,000	-59,474,000	-64,216,000	-57,291,000	-64,023,000	-64,238,000	-83,142,000	-97,199,000	-103,458,000	-78,352,000	-91,627,000	-83,521,000	-79,633,000	-83,011,000	-70,632,000	-44,814,000	-15,862,000	-56,817,000	-49,759,000	-48,935,000	-65,294,000	-67,220,000	-63,925,000		-76,480,000	-51,527,000	-53,615,000		-41,622,000	-24,477,000	-22,979,000											-20,904,000	-20,220,000	-16,291,000
total shareholders’ equity	2,085,304,000	2,010,989,000	1,965,814,000	1,918,808,000	2,018,025,000						1,997,746,000	1,966,516,000	1,889,686,000	1,827,106,000	1,751,154,000	1,701,011,000	1,713,322,000	1,702,531,000			1,547,942,000	1,530,854,000																	895,369,000	879,280,000				846,935,000	820,066,000	820,682,000	793,413,000	795,265,000	777,041,000	748,528,000	726,763,000	737,541,000	719,509,000	694,565,000	680,605,000	674,442,000	644,497,000	597,506,000	589,354,000	586,122,000
total liabilities and shareholders’ equity	2,550,601,000	2,522,699,000	2,526,148,000	2,557,868,000	2,644,259,000	2,670,424,000	2,736,017,000	2,703,867,000	2,721,170,000	2,730,753,000	2,755,360,000	2,638,692,000	2,599,696,000	2,363,401,000	2,350,721,000	2,294,805,000	2,299,892,000	2,304,846,000	2,270,187,000	2,262,957,000	2,084,642,000	2,067,866,000	2,053,096,000	2,027,589,000	1,999,022,000	1,998,415,000	1,925,028,000	1,884,410,000	1,872,618,000	1,844,832,000	1,872,198,000	1,593,202,000	1,617,808,000	1,555,422,000	1,527,380,000	1,558,219,000					1,121,924,000	1,133,453,000
short-term available-for-sale investments								1,072,000	5,397,000	5,520,000		23,739,000	29,915,000	32,074,000	37,818,000	74,462,000	70,351,000	67,135,000	38,740,000	32,463,000	90,108,000	117,426,000	117,986,000	124,268,000	104,872,000	133,657,000	58,520,000	65,147,000	83,229,000	70,647,000	69,047,000	59,764,000	89,826,000	40,927,000	50,261,000	66,102,000	53,780,000	56,559,000	52,381,000	31,598,000	18,874,000	51,471,000	38,423,000	56,389,000	53,503,000	46,970,000	32,573,000	44,786,000	96,528,000	88,454,000	100,843,000	169,151,000	162,162,000	142,809,000	142,262,000	152,311,000	124,325,000	56,758,000	54,120,000	63,200,000
deferred tax asset				10,307,000
accounts receivables						217,940,000	223,688,000	241,394,000	227,887,000	207,451,000	204,570,000	218,468,000	216,415,000	184,763,000	174,174,000	194,548,000	202,095,000	152,896,000	147,548,000	145,385,000				122,534,000	117,452,000	111,753,000	122,724,000	137,466,000	133,927,000	113,283,000	114,753,000	120,296,000	109,759,000	98,498,000	107,325,000	116,830,000			109,813,000	93,393,000				70,034,000
bio-techne’s shareholders’ equity:
total bio-techne’s shareholders’ equity						2,078,492,000	2,138,650,000	2,068,850,000	2,014,375,000	1,963,559,000	1,997,746,000	1,966,516,000	1,889,686,000	1,827,106,000	1,751,154,000	1,701,770,000	1,714,376,000
contingent consideration payable											1,750,000	3,500,000	5,250,000		7,400,000			2,000,000	5,000,000	4,000,000	5,070,000	4,983,000	5,788,000	5,938,000	6,150,000	9,871,000	8,170,000	3,400,000					3,500,000	53,300,000	40,900,000	65,100,000	67,280,000	63,500,000	49,900,000	38,500,000				39,024,000	35,000,000	35,000,000
current liabilities held-for-sale									689,000	1,593,000
right of use asset											102,277,000	98,326,000	97,976,000	83,937,000	69,745,000	65,556,000	63,450,000	64,293,000	71,396,000	73,834,000	71,830,000	68,154,000	70,018,000	71,465,000	73,751,000	75,824,000	76,962,000
noncontrolling interest																-759,000	-1,054,000	-458,000	7,590,000	8,263,000	8,489,000	8,938,000
current portion of long-term debt obligations																12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000	12,500,000		12,500,000
long-term contingent consideration payable														7,000,000	8,100,000	5,000,000	4,800,000	7,000,000	17,600,000	25,400,000	7,100,000	5,599,000	199,000	199,000	1,700,000	2,684,000	5,130,000	9,200,000	2,200,000	6,000,000	6,800,000						3,200,000	28,600,000	32,400,000
liabilities and shareholders' equity
bio-techne's shareholders' equity:
total bio-techne’s shareholders' equity																		1,702,989,000
total bio-techne's shareholders' equity																			1,639,365,000
total shareholder's equity																			1,646,955,000
total bio-techne shareholders' equity																				1,562,971,000	1,539,453,000	1,521,916,000
total shareholders' equity																				1,571,234,000			1,439,285,000	1,381,192,000	1,291,268,000	1,323,348,000	1,174,224,000	1,165,589,000	1,146,266,000	1,096,425,000	1,109,469,000	1,079,061,000	1,058,292,000	997,819,000	959,810,000	949,627,000	907,925,000	890,573,000			852,962,000	856,343,000	837,947,000
accounts receivable, net of 1,428 and 775 of reserves, respectively																					157,790,000
accounts receivable, net of 1,526 and 775 of reserves, respectively																						128,243,000
accounts receivable, net of 1,429 and 775 of reserves, respectively																							122,635,000
shareholders' equity:
current portion of contingent consideration payable																													3,400,000
long-term debt obligations, net of deferred financing costs of 360 and 0 respectively																													509,765,000
cash flows from operating activities:
net earnings																													79,612,000	34,958,000	17,403,000		84,449,000	64,710,000	15,863,000								22,707,000
adjustments to reconcile net earnings to net cash from operating activities:
depreciation and amortization																													58,252,000	38,930,000	19,052,000		47,311,000	31,038,000	15,423,000								10,685,000
costs recognized on sale of acquired inventory																													2,804,000	1,869,000	935,000		2,013,000	582,000	318,000								1,113,000
stock-based compensation expense																													24,151,000	18,426,000	11,565,000		13,587,000	8,839,000	3,795,000								2,038,000
fair value adjustment to contingent consideration payable																													-1,100,000	-700,000	-200,000		20,100,000	19,900,000	7,500,000
payments of contingent consideration																																	-26,200,000	-35,000,000	-35,000,000
impairment of investment																																	16,226,000
fair value adjustment on available for sale investments																													-2,907,000	9,366,000	2,202,000
other operating activity																													2,255,000	2,340,000	2,217,000		1,664,000	1,556,000	277,000
change in operating assets and operating liabilities, net of acquisition:
accounts receivable																													-13,136,000	7,848,000
prepaid expenses																													-1,000,000	-2,258,000			858,000	1,321,000	10,576,000		10,320,000	8,154,000	7,849,000		6,865,000	6,942,000	6,201,000		5,187,000	5,118,000	4,419,000	2,588,000	2,047,000	1,980,000	2,285,000	1,527,000	1,733,000	1,711,000	1,769,000	1,503,000	1,428,000	1,020,000	1,170,000	1,041,000
trade accounts payable and accrued expenses																													7,977,000	5,385,000			1,665,000	-4,736,000	-563,000								-416,000
net cash from operating activities																													125,673,000	86,011,000	39,448,000		105,528,000	83,878,000	44,696,000								31,833,000
cash flows from investing activities:
acquisitions, net of cash acquired																													-272,286,000	-272,287,000	-272,229,000		-65,066,000	-10,644,000	-10,634,000								-82,970,000
proceeds from maturities of available-for-sale investments																													17,215,000	5,334,000			6,563,000	6,563,000	3,502,000								3,930,000
purchases of available-for-sale investments																													-37,693,000	-26,000,000	-11,694,000		-3,061,000	-3,061,000
purchases of property and equipment																													-13,719,000	-8,794,000			-15,116,000	-11,608,000
net cash from investing activities																													-306,483,000	-301,747,000	-288,113,000		-76,680,000	-18,750,000	-12,405,000								-85,161,000
cash flows from financing activities:
cash dividends																													-36,237,000	-24,151,000	-12,066,000		-35,941,000	-23,946,000	-11,958,000								-11,894,000
proceeds from stock option exercises																													27,029,000	18,860,000	16,453,000		13,724,000	6,699,000	3,806,000								1,128,000
re-purchases of common stock																													-15,405,000	-15,404,000
borrowings under credit agreement																													580,000,000	580,000,000
payments on credit agreement																													-396,375,000	-373,250,000
other financing																													-4,731,000	-4,731,000			-4,339,000	-2,157,000	-1,802,000
net cash from financing activities																													154,281,000	181,324,000	222,531,000		-36,356,000	-35,404,000	-50,954,000								41,865,000
effect of exchange rate changes on cash and cash equivalents																													99,000	-1,692,000	-1,182,000		2,504,000	122,000	-485,000								5,773,000
net increase in cash and cash equivalents																													-26,429,000	-36,104,000				29,846,000	-19,148,000
cash and cash equivalents at beginning of period																													121,990,000	121,990,000	121,990,000		91,612,000	91,612,000	91,612,000								54,532,000
cash and cash equivalents at end of period																													95,561,000	85,886,000	94,674,000		86,608,000	121,458,000	72,464,000								48,842,000
supplemental disclosure of cash flow information:
cash paid for interest																													16,110,000	10,812,000	3,229,000		6,877,000	3,630,000
cash paid for income taxes																													26,637,000	19,135,000	8,447,000		31,103,000	27,873,000
contingent portion of long-term debt obligations																														12,500,000
long-term debt obligations, net of deferred financing costs of 388 and 0 respectively																														532,869,000
long-term debt obligations, net of deferred financing costs of 402 and 0, respectively																															548,973,000
trade accounts and other receivables																															8,307,000		9,399,000	18,636,000	9,550,000								-3,763,000
trade accounts payable, accrued expenses, and contract liabilities																															3,107,000
additions to property and equipment																															-4,190,000				-5,273,000								-6,121,000
proceeds from long-term debt																															580,000,000
repayments of long-term debt																															-357,125,000
debt issuance costs																															-3,004,000
other financing activity																															-1,727,000
net decrease in cash and cash equivalents																															-27,316,000		-5,004,000										-5,690,000
deferred revenue, current																																7,067,000				5,968,000	6,072,000	4,852,000	4,484,000		5,218,000	3,139,000	3,839,000		3,491,000	2,811,000	2,545,000
balances at june 30, 2015																																37,153,000
other comprehensive loss
surrender and retirement of stock to exercise options																																-3,000
common stock issued for exercise of options																																69,000
common stock issued for restricted stock awards																																23,000
tax benefit from exercise of stock options
common stock issued to employee stock purchase plan																																9,000
employee stock purchase plan expense
balances at june 30, 2016																																37,254,000
other comprehensive income
balances at june 30, 2017																																37,356,000
balances at june 30, 2018																																37,608,000
prepaid expenses and other																																	18,725,000	16,923,000
deferred revenue																																	7,841,000	6,016,000	5,374,000					4,717,000				3,380,000
purchase of equity investment
excess tax benefit from stock option exercises																																											131,000
borrowings under line-of-credit agreement																																	55,000,000	25,000,000									77,000,000
payments on line-of-credit																																	-6,000,000	-6,000,000	-6,000,000								-24,500,000
related party note payable, current																																					14,578,000	3,595,000	3,733,000	3,759,000	3,808,000	3,789,000	3,868,000	4,024,000	3,004,000	5,983,000	5,949,000	5,949,000
trade accounts receivable, less allowance for doubtful accounts of 659 and 555, respectively																																					118,335,000
total liabilities and shareholders' equity																																					1,533,431,000	1,520,025,000
trade accounts receivable, less allowance for doubtful accounts of 614 and 555, respectively																																						104,368,000
accumulated other comprehensive income																																								-70,405,000				-30,593,000				-5,388,000	-3,909,000	-9,953,000	-14,321,000	14,553,000	12,837,000	10,250,000	12,141,000	21,775,000	6,877,000
trade accounts receivable, less allowance for doubtful accounts of 417 and 555, respectively																																									87,156,000
other receivables																																									1,065,000	1,195,000	972,000		942,000	1,173,000	668,000	7,127,000	1,957,000	2,129,000	1,928,000	1,992,000	1,736,000	2,138,000	1,791,000	2,073,000	1,812,000	2,194,000	1,547,000	1,946,000
trade accounts receivable, less allowance for doubtful accounts of 549 and 555, respectively																																										66,135,000
trade accounts receivable, less allowance for doubtful accounts of 500 and 555, respectively																																											70,915,000
other																																											26,000
distributions from unconsolidated entities
available-for-sale investments																																														4,085,000	3,575,000	3,575,000	151,357,000	162,590,000	138,477,000	132,376,000	135,765,000	128,569,000	131,713,000	143,966,000	145,129,000	148,114,000	148,949,000	131,988,000
investments in unconsolidated entities																																															10,000,000	10,446,000				531,000				1,056,000	1,522,000	19,176,000	19,435,000	19,633,000
related party note payable, long-term																																													8,011,000	7,037,000	6,997,000	6,997,000
trade accounts receivable, less allowance for doubtful accounts of 591 and 487, respectively																																													65,885,000
trade accounts receivable, less allowance for doubtful accounts of 572 and 487, respectively																																														57,214,000
income taxes receivable																																														4,182,000											3,816,000
trade accounts receivable, less allowance for doubtful accounts of 492 and 487, respectively																																															60,869,000
trade accounts receivable, less allowance for doubtful accounts of 487 and 428, respectively																																																47,874,000
commitments and contingencies
trade accounts receivable, less allowance for doubtful accounts of 488 and 428, respectively																																																	48,501,000
trade accounts receivable, less allowance for doubtful accounts of 494 and 428, respectively																																																		38,306,000
trade accounts receivable, less allowance for doubtful accounts of 467 and 428, respectively																																																			42,240,000
trade accounts receivable, less allowance for doubtful accounts of 428 and 455, respectively																																																				38,183,000
trade accounts receivable, less allowance for doubtful accounts of 473 and 455, respectively																																																					38,138,000
trade accounts receivable, less allowance for doubtful accounts of 478 and 455, respectively																																																						32,187,000
trade accounts receivable, less allowance for doubtful accounts of 458 and 455, respectively																																																							35,119,000
trade accounts receivable, less allowance for doubtful accounts of 455 and 448, respectively																																																								35,668,000
trade accounts receivable, less allowance for doubtful accounts of 451 and 448, respectively																																																									39,114,000
trade accounts receivable, less allowance for doubtful accounts of 450 and 448, respectively																																																										32,351,000
trade accounts receivable, less allowance for doubtful accounts of 444 and 448, respectively																																																											34,092,000
trade accounts receivable, less allowance for doubtful accounts of 448 and 347, respectively																																																												35,914,000
other accounts payable and accrued expenses																																																												2,688,000

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-03-31	2011-12-31	2011-09-30

cash flows from operating activities:
net earnings	51,047,000	38,009,000	38,185,000	-17,678,000	22,588,000	34,890,000	33,600,000														45,403,000	46,143,000	33,395,000	58,845,000	36,433,000	119,620,000	14,398,000	16,460,000	44,654,000	17,555,000	17,403,000	41,701,000	19,739,000	48,847,000	15,863,000	32,102,000	21,389,000	6,314,000	16,281,000	25,626,000	30,291,000	25,852,000	22,707,000	26,329,000	24,290,000	33,209,000	23,907,000	26,824,000	31,641,000	25,055,000	27,428,000	28,411,000	33,118,000	25,364,000	25,668,000	85,090,000	53,334,000	27,521,000
adjustments to reconcile net earnings to net cash from operating activities:
depreciation and amortization	24,169,000	24,709,000	24,340,000	27,111,000	27,571,000	27,084,000	28,137,000	28,057,000	27,311,000	27,803,000	28,540,000	26,923,000	26,971,000	26,703,000	26,641,000	25,866,000	25,367,000	25,102,000	24,734,000	24,672,000	21,103,000	20,884,000	21,088,000	20,991,000	21,108,000	20,553,000	20,085,000	19,919,000	19,322,000	19,878,000	19,052,000	17,152,000	16,273,000	15,615,000	15,423,000	14,748,000	16,038,000	15,606,000	13,644,000	10,661,000	10,828,000	10,590,000	10,685,000	9,499,000	9,273,000	9,895,000	8,559,000	5,311,000	4,918,000	4,856,000	4,090,000	3,042,000	3,001,000	3,173,000	3,105,000	9,366,000	6,314,000	3,135,000
costs recognized on sale of acquired inventory				197,000	181,000	185,000	188,000	179,000	186,000	183,000	181,000	0	0	100,000	300,000	0	0	84,000	1,512,000	1,474,000	68,000							935,000	935,000	934,000	935,000	442,000	1,431,000	264,000	318,000	-8,168,000	3,136,000	3,850,000	4,219,000	1,992,000	1,082,000	1,244,000	1,113,000	1,709,000	897,000	1,188,000	3,167,000	3,168,000	1,177,000	1,404,000	1,731,000	1,005,000	1,032,000	1,200,000	1,264,000	5,870,000	3,915,000	2,148,000
deferred income taxes	2,842,000	-72,000	5,275,000	-32,282,000	-5,408,000	-8,077,000	-5,340,000	-9,551,000	-7,582,000	-10,723,000	-11,591,000	-6,916,000	-16,286,000	-1,598,000	-4,767,000	-1,072,000	655,000	1,826,000	5,407,000	-21,408,000	-6,239,000	668,000	-452,000	4,489,000	-6,164,000	15,412,000	-607,000	-2,468,000	-2,008,000	-5,338,000	-3,768,000	1,314,000	-4,493,000	-41,353,000	-2,184,000	1,890,000	-939,000	-3,214,000	-1,170,000	-1,245,000	57,000	-321,000	-1,115,000	2,098,000	289,000	534,000	-1,617,000	1,245,000	-1,092,000	-1,677,000	-1,329,000	-480,000	-567,000	-710,000	-777,000	-7,753,000	-7,472,000	-1,066,000
stock-based compensation expense	10,495,000	13,958,000	11,682,000	4,550,000	11,391,000	14,708,000	10,184,000	7,063,000	8,133,000	12,753,000	10,093,000	-2,085,000	10,110,000	16,744,000	14,461,000	8,406,000	8,071,000	13,969,000	11,737,000	9,808,000	10,643,000	15,578,000	12,953,000	6,017,000	7,855,000	10,129,000	8,366,000	8,129,000	5,725,000	6,861,000	11,565,000	14,653,000	4,748,000	5,044,000	3,795,000	3,412,000	3,974,000	4,069,000	3,176,000	2,754,000	2,317,000	2,321,000	2,038,000	1,232,000	1,288,000	2,075,000	1,362,000	888,000	740,000	1,326,000	569,000	490,000	286,000	785,000	303,000	1,389,000	1,148,000	290,000
loss on equity method investment	739,000	-110,000	-294,000	-1,107,000	589,000	-46,000	-374,000	799,000	1,747,000	1,913,000	2,382,000
loss on investments	2,371,000	2,017,000	-2,054,000
asset impairment restructuring	0			11,351,000	120,000	3,802,000	6,039,000									0	0	0	546,000
leases	-839,000	-868,000	-912,000	183,000	10,000	47,000	445,000	-124,000	636,000	583,000	613,000	625,000	794,000	-1,905,000	2,545,000	-227,000	-473,000	-422,000	-79,000	-8,000	-30,000
recovery of assets held-for-sale	0	0	-6,789,000
other operating activity	-42,000	-338,000	1,001,000	148,000	222,000	-442,000	747,000	162,000	166,000	74,000	182,000	159,000	184,000	144,000	-32,000	119,000	166,000	-114,000	497,000	144,000	-932,000	129,000	195,000	-58,000	-866,000	28,000	164,000	70,000	-85,000	123,000	2,217,000	-888,000	108,000	1,279,000	277,000
change in operating assets and operating liabilities:
trade accounts and other receivables	-31,256,000	941,000	22,392,000	28,861,000	-15,669,000	-623,000	21,563,000	-17,922,000	-22,944,000	4,734,000	15,599,000	-92,000	-32,200,000	-5,910,000	17,335,000	3,334,000	-51,583,000	-5,710,000	-3,637,000	17,161,000	-30,383,000	-3,237,000	910,000	3,864,000	-7,258,000	11,355,000	-1,405,000				8,307,000	-12,099,000	-9,237,000	9,086,000	9,550,000	257,000	-13,537,000	3,770,000	-10,176,000	-8,365,000	-20,029,000	9,176,000	-3,763,000	-4,431,000	-8,959,000	1,221,000	422,000	8,007,000	-9,753,000	2,997,000	-106,000	-15,000	-5,964,000	2,592,000	1,053,000	-4,645,000	1,263,000	1,591,000
inventories	3,431,000	-1,939,000	-14,002,000	-6,604,000	173,000	-8,908,000	-2,805,000	-4,616,000	-22,000	-4,361,000	-5,216,000	-1,351,000	-10,454,000	-7,677,000	-10,685,000	-15,973,000	-7,334,000	-5,719,000	-2,981,000	-3,025,000	-3,529,000	1,382,000	-1,968,000	-4,852,000	-5,628,000	-3,661,000	-720,000	-2,097,000	-3,338,000	-1,534,000	-6,678,000	-1,751,000	-4,063,000	-2,067,000	-5,446,000	2,844,000	-1,079,000	-83,000	-2,414,000	-2,389,000	322,000	-1,383,000	-3,176,000	168,000	-623,000	-1,933,000	-2,326,000	-2,191,000	539,000	-947,000	-296,000	-184,000	-670,000	-278,000	-1,084,000	-1,586,000	-929,000	-226,000
prepaid expenses	-750,000	2,875,000	380,000	-7,155,000	-6,812,000	2,753,000	-3,158,000	-1,163,000	1,166,000	-577,000	-2,572,000	972,000	-3,552,000	755,000	-2,760,000	494,000	3,449,000	-1,173,000	-5,852,000									302,000	1,258,000			1,924,000	-463,000	1,273,000	48,000	-175,000	-2,148,000	-370,000	605,000	665,000	464,000	-744,000	-766,000	-25,000	-95,000	-508,000	8,000	-516,000	-69,000	336,000	-305,000	207,000	-47,000	59,000	-252,000	-393,000	7,000	-145,000
trade accounts payable, accrued expenses, contract liabilities, and other	5,154,000	-5,992,000	-2,115,000	-13,315,000	-610,000	10,882,000	-10,911,000	18,609,000	1,778,000	8,077,000	-2,695,000	-2,261,000	5,894,000	-10,140,000	-1,401,000	1,512,000	11,404,000	2,128,000	-2,303,000		3,574,000	1,706,000	6,918,000		2,916,000	5,659,000	1,456,000
salaries, wages and related accruals	9,509,000	1,393,000	-22,101,000	3,402,000	8,124,000	12,128,000	-8,246,000	5,455,000	11,468,000	-2,148,000	-2,157,000	-1,799,000	10,506,000	-4,905,000	-28,360,000	5,701,000	12,467,000	8,525,000	-18,933,000	6,707,000	15,542,000	9,767,000	-11,480,000	7,642,000	5,095,000	798,000	-10,983,000	5,115,000	3,835,000	4,539,000	-8,476,000	4,070,000	-4,613,000	4,089,000	-3,635,000	3,390,000	1,259,000	4,791,000	-7,257,000	3,829,000	2,883,000	717,000	-1,704,000	986,000	315,000	-2,150,000	2,528,000	-429,000	1,320,000	-1,277,000	1,420,000	-728,000	1,026,000	-790,000	400,000	1,351,000	-253,000	825,000
income taxes payable	9,791,000	4,575,000	-27,403,000			-4,037,000	-6,180,000			13,051,000	-22,936,000	-6,340,000	-9,587,000	10,496,000	2,939,000	11,875,000	-3,108,000	13,718,000	-19,818,000	9,898,000	-454,000	5,365,000	-1,383,000	-17,386,000	-2,231,000	11,153,000	1,233,000	-1,051,000	429,000	-4,034,000	-4,864,000	11,983,000	5,593,000	-11,122,000	3,750,000	424,000	2,005,000	-4,580,000	2,850,000	-264,000	1,794,000	-7,436,000	6,204,000	-967,000	3,597,000	-1,876,000	1,127,000	-5,085,000	3,796,000	-741,000	91,000	-1,955,000	2,134,000	-234,000	-782,000	-4,748,000	-4,402,000	-1,449,000
net cash from operating activities	86,661,000	82,411,000	27,585,000	98,201,000	41,120,000	84,346,000	63,889,000	75,496,000	80,986,000	83,116,000	59,383,000	83,393,000	50,535,000	64,384,000	56,081,000	102,717,000	73,128,000	100,993,000	48,434,000	122,020,000	74,866,000	89,269,000	66,009,000	44,791,000	49,469,000	70,418,000	40,539,000	55,946,000	39,662,000	46,563,000	39,448,000	64,839,000	21,650,000	39,182,000	44,696,000	50,827,000	24,939,000	41,180,000	26,502,000	36,361,000	37,137,000	38,539,000	31,833,000	37,139,000	30,776,000	35,726,000	35,718,000	37,921,000	34,934,000	31,322,000	32,585,000	29,987,000	33,025,000	31,287,000	29,263,000	89,333,000	54,870,000	34,432,000
capital expenditures	-9,086,000	-5,921,000	-5,363,000	-4,890,000	-10,123,000	-6,821,000	-9,172,000	-17,980,000	-16,441,000	-14,864,000	-13,592,000	-10,831,000	-11,748,000	-6,109,000	-9,556,000	-13,570,000	-15,100,000	-10,168,000	-6,070,000	-11,316,000	-10,602,000	-11,445,000	-10,938,000	-17,373,000	-9,282,000	-14,564,000	-10,525,000	0	-4,925,000	0	-4,190,000	0	-3,508,000	0	-5,273,000	-5,868,000	-4,016,000	-2,853,000	-2,442,000	-3,054,000	-2,836,000	-4,887,000	-6,121,000	-6,934,000	-4,924,000	-3,142,000	-4,905,000	-2,102,000	-4,261,000	-3,647,000	-3,811,000	-5,346,000	-6,373,000	-8,220,000	-2,515,000	-4,884,000	-3,297,000	-1,096,000
free cash flows	77,575,000	76,490,000	22,222,000	93,311,000	30,997,000	77,525,000	54,717,000	57,516,000	64,545,000	68,252,000	45,791,000	72,562,000	38,787,000	58,275,000	46,525,000	89,147,000	58,028,000	90,825,000	42,364,000	110,704,000	64,264,000	77,824,000	55,071,000	27,418,000	40,187,000	55,854,000	30,014,000	55,946,000	34,737,000	46,563,000	35,258,000	64,839,000	18,142,000	39,182,000	39,423,000	44,959,000	20,923,000	38,327,000	24,060,000	33,307,000	34,301,000	33,652,000	25,712,000	30,205,000	25,852,000	32,584,000	30,813,000	35,819,000	30,673,000	27,675,000	28,774,000	24,641,000	26,652,000	23,067,000	26,748,000	84,449,000	51,573,000	33,336,000
cash flows from investing activities:
proceeds from sale of available-for-sale investments				0	0	0	1,085,000	4,324,000	0	0	23,759,000
additions to property and equipment	-9,086,000	-5,921,000	-5,363,000	-4,890,000	-10,123,000	-6,821,000	-9,172,000	-17,980,000	-16,441,000	-14,864,000	-13,592,000	-10,831,000	-11,748,000	-6,109,000	-9,556,000	-13,570,000	-15,100,000	-10,168,000	-6,070,000	-11,316,000	-10,602,000	-11,445,000	-10,938,000	-17,373,000	-9,282,000	-14,564,000	-10,525,000				-4,190,000				-5,273,000	-5,868,000	-4,016,000	-2,853,000	-2,442,000	-3,054,000	-2,836,000	-4,887,000	-6,121,000	-6,934,000	-4,924,000	-3,142,000	-4,905,000	-2,102,000	-4,261,000	-3,647,000	-3,811,000	-5,346,000	-6,373,000	-8,220,000	-2,515,000	-4,884,000	-3,297,000	-1,096,000
distributions from wilson wolf	3,269,000	0	1,351,000
investment in spear bio				0	0	0	-15,000,000
proceeds from sale of assets held-for-sale	0	0	4,617,000	658,000	0
net cash from investing activities	-5,817,000	-5,921,000	605,000	406,000	-8,873,000	-5,032,000	-21,684,000	-8,808,000	-16,441,000	-23,671,000	-154,110,000	-4,756,000	-241,096,000	-109,000	-19,688,000	-18,570,000	-35,993,000			-226,903,000	129,000	-8,604,000	-8,138,000	-10,473,000	19,358,000	33,295,000	-15,085,000	-30,316,000	-4,736,000	-13,634,000	-288,113,000	37,968,000	-57,930,000	-6,345,000	-12,405,000	-4,701,000	4,000	-32,975,000	-268,282,000	-3,618,000	-13,986,000	-4,805,000	-85,161,000	-5,522,000	-3,148,000	-63,069,000	-354,754,000	163,685,000	-81,000	-8,783,000	-105,133,000	-4,759,000	-11,525,000	-9,000,000	-5,920,000	-19,134,000	-11,278,000	-10,449,000
cash flows from financing activities:
cash dividends	-12,518,000	-12,470,000	-12,444,000	-12,387,000	-12,580,000	-12,736,000	-12,688,000	-12,627,000	-12,579,000	-12,559,000	-12,654,000	-12,597,000	-12,582,000	-12,561,000	-12,545,000	-12,539,000	-12,577,000	-12,576,000	-12,493,000	-12,448,000	-12,446,000	-12,392,000	-12,336,000	-12,258,000	-12,279,000	-12,196,000	-12,169,000	-12,127,000	-12,086,000	-12,085,000	-12,066,000	-12,032,000	-11,995,000	-11,988,000	-11,958,000	-11,511,000	-11,943,000	-11,939,000	-11,932,000	-11,909,000	-11,902,000	-11,902,000	-11,894,000	-11,888,000	-11,883,000	-11,863,000	-11,472,000	-11,469,000	-11,440,000	-11,434,000	-11,051,000	-11,050,000	-11,053,000	-11,048,000	-10,312,000	-30,707,000	-20,387,000	-10,026,000
proceeds from stock option exercises	29,959,000	4,739,000	23,495,000	6,226,000	14,872,000	5,540,000	25,101,000	22,934,000	18,331,000	5,276,000	14,394,000	8,414,000	4,422,000	5,027,000	11,950,000	8,809,000	11,846,000	18,620,000	37,880,000	10,100,000	22,655,000	16,919,000	15,418,000	32,493,000	11,243,000	18,295,000	8,952,000	10,921,000	8,169,000	2,407,000	16,453,000	5,446,000	7,025,000	2,893,000	3,806,000	1,627,000	1,525,000	79,000	2,026,000	3,535,000	748,000	47,000	1,128,000	-1,000	2,702,000	5,166,000	1,864,000	3,198,000	1,568,000	2,415,000	1,145,000	281,000	0	688,000	136,000	667,000	45,000	45,000
repurchases of common stock	0	0	-24,000
borrowings under line-of-credit agreement				66,000,000				0	0	65,000,000	160,000,000	0	170,000,000	0	449,661,000	0	40,000,000	40,000,000	10,000,000													0	30,000,000			0	90,000	24,910,000	343,500,000	0	0	0	77,000,000	0	0	38,000,000	125,000,000
repayments of long-term debt	-60,000,000	-40,000,000	-46,000,000	-50,000,000	-8,000,000	0	-19,000,000	-70,000,000	-58,000,000	-58,000,000	-70,000,000	-20,000,000	0	-64,661,000	-441,000,000		-63,125,000	-58,125,000	-51,125,000		-16,125,000	-92,125,000	-33,125,000		-3,125,000	-103,125,000	-19,125,000				-357,125,000
taxes paid on rsus and net share settlements	-157,000	-1,255,000	-9,231,000	-234,000	-291,000	-1,013,000	-4,984,000	-402,000	-168,000	-1,074,000	-20,228,000	-39,000	-11,001,000	0	-17,853,000
net cash from financing activities	-42,716,000	-48,986,000	-44,204,000	-90,452,000	-68,045,000	-83,837,000	-11,571,000	-60,095,000	-52,416,000	-81,399,000	71,512,000	-24,222,000	150,839,000	-72,195,000	-31,806,000	-65,728,000	-84,065,000	-53,376,000	-39,684,000	117,688,000	-55,227,000	-90,079,000	-34,933,000	-44,720,000	-17,786,000	-97,027,000	-24,269,000	-19,897,000	-27,043,000	-41,207,000	222,531,000	-62,832,000	-952,000	15,550,000	-50,954,000	-16,624,000	-24,439,000	-11,885,000	242,334,000	-32,047,000	-19,535,000	-13,366,000	41,865,000	-85,677,000	-11,000,000	25,483,000	102,470,000	-8,009,000	-9,912,000	-8,983,000	-9,902,000	-12,584,000	-11,048,000	-10,297,000	-10,748,000	-52,179,000	-38,984,000	-21,556,000
effect of exchange rate changes on cash and cash equivalents	-1,188,000	413,000	-1,210,000	13,361,000	-1,081,000	-5,468,000	5,115,000	5,283,000	-2,346,000	3,423,000	-8,693,000	-1,126,000	2,322,000	7,345,000	-11,897,000	-6,673,000	-4,094,000	3,075,000	-4,400,000	150,000	842,000	5,536,000	-159,000	811,000	-5,117,000	3,715,000	-2,180,000	-407,000	1,791,000	-510,000	-1,182,000	-4,593,000	2,382,000	607,000	-485,000	2,270,000	400,000	-7,423,000	5,248,000	-2,172,000	-355,000	-6,758,000	5,773,000	2,145,000	-3,149,000	-3,411,000	-3,763,000	1,368,000	260,000	990,000	2,520,000	429,000	-3,025,000	491,000	1,535,000	-353,000	-1,227,000	-805,000
net change in cash and cash equivalents	36,940,000	27,917,000	-17,224,000	21,516,000	-36,879,000	-9,991,000	35,749,000	11,876,000	9,783,000	-18,531,000	-31,908,000	53,289,000	-37,400,000	-575,000	-7,310,000	11,746,000	-51,024,000	15,524,000	-2,770,000
cash and cash equivalents at beginning of period	0	0	162,186,000	0	0	0	151,791,000	0	0	0	180,571,000	0	0	0	172,567,000	0	0	0	199,091,000		0	0	146,625,000		0	0	100,886,000		0	0	121,990,000		0	0	91,612,000		0	0	64,237,000		0	0	54,532,000		0	0	318,568,000		0	0	163,786,000		0	0	116,675,000	77,613,000	77,613,000	77,613,000
cash and cash equivalents at end of period	36,940,000	27,917,000	144,962,000	21,516,000	-36,879,000	-9,991,000	187,540,000	11,876,000	9,783,000	-18,531,000	148,663,000	53,289,000	-37,400,000	-575,000	165,257,000	11,746,000	-51,024,000	15,524,000	196,321,000		20,610,000	-3,878,000	169,404,000		45,923,000	10,402,000	99,891,000		9,675,000	-8,788,000	94,674,000		-34,850,000	48,994,000	72,464,000		904,000	-10,653,000	69,589,000		3,261,000	13,610,000	48,842,000		13,479,000	-5,271,000	98,239,000		25,201,000	14,546,000	83,856,000		7,427,000	12,481,000	130,805,000	95,280,000	80,994,000	79,235,000
supplemental disclosure of cash flow information:
cash paid for income taxes	5,672,000	5,871,000	30,812,000		18,306,000	21,103,000	16,490,000		7,201,000	4,848,000	32,797,000		36,172,000	11,519,000	14,892,000		7,597,000	3,298,000	12,070,000		6,950,000	4,973,000	6,034,000		17,814,000	4,585,000	2,452,000		7,502,000	10,688,000	8,447,000		3,230,000
cash paid for interest	2,985,000	3,987,000	4,822,000		4,401,000	4,626,000	5,205,000		3,807,000	4,080,000	4,506,000		154,000	2,210,000	3,409,000		2,378,000	3,037,000	3,107,000		2,950,000	3,542,000	4,237,000		4,327,000	4,777,000	5,092,000		5,298,000	7,583,000	3,229,000		3,247,000
change in operating assets and operating liabilities, net of acquisition:
fair value adjustment to contingent consideration payable								0	0	-1,750,000	-1,750,000	-1,750,000	-1,750,000	-8,500,000	-100,000	200,000	-4,200,000	-13,600,000	-2,800,000	-888,000	1,588,000	4,750,000	-150,000	-300,000	-705,000	-600,000	700,000	-900,000	-400,000	-500,000	-200,000	0	200,000	12,400,000	7,500,000	4,300,000	1,700,000	10,500,000	1,900,000
gain on sale of ccxi investment
gain on sale of eminence												0	0	0	-11,682,000
impairment of assets held-for-sale								15,925,000	0
income taxes receivable				16,381,000
purchases of available-for-sale investments								0	0			0	0	-6,000,000	-14,500,000	-5,000,000	-34,498,000	0	-13,500,000		-12,500,000	-945,000	-26,239,000		-25,629,000	-9,228,000	-15,871,000		-11,693,000	-14,306,000	-11,694,000		0
proceeds from sale of ccxi investment												0	0	0	73,219,000
acquisitions, net of cash acquired								0	0	-3,281,000	-166,426,000	0	0	0	-101,184,000					-215,587,000	0							-17,206,000	1,000	-58,000	-272,229,000	-2,785,000	-54,422,000	-10,000	-10,634,000	156,000	1,988,000	3,075,000	-259,004,000	-535,000	-8,000,000	82,000	-82,970,000	0	0	-59,927,000	-360,175,000	-6,031,000
distributions from (investments in) wilson wolf						0	1,403,000	4,848,000	0	0	2,149,000
proceeds from sale of eminence												0	0	0	17,824,000
re-purchases of common stock				-100,057,000	-100,046,000			0	0			0	0	0	-19,562,000	-58,818,000	-60,838,000											0	-1,000
other financing activity												0	0	0	-2,457,000	23,406,000	629,000	-1,000	-23,246,000		-6,133,000	-2,481,000	-4,890,000		-114,000	-1,000	-1,927,000				-1,727,000
fair value adjustment on available-for-sale investments								0	0	0	-283,000	681,000
impairment (recovery) of assets held-for-sale
net earnings, including noncontrolling interest								40,588,000	49,058,000	27,466,000	50,993,000	75,484,000	70,219,000	50,005,000	89,734,000	61,915,000	60,144,000	72,059,000	68,981,000
contingent consideration payments - operating																0
eminence impairment																0	0
investment of forward purchase contract																0	0
contingent consideration payments - financing																0
proceeds from maturities of available-for-sale investments												6,075,000	2,652,000	12,000,000	14,509,000	0	13,605,000	0	12,450,000				29,039,000				11,311,000		11,881,000				0	3,061,000	3,502,000		2,032,000					0	3,930,000		2,116,000	0	9,880,000	12,681,000	12,561,000	18,103,000	16,090,000	8,116,000	31,665,000	10,721,000	11,601,000	56,273,000	36,935,000	24,763,000
investment in unconsolidated entity																				0
investment in wilson wolf												0
loss on investment													0	0	-37,176,000
fair value adjustment on available for sale investments														72,000	-911,000	567,000	18,103,000	-28,395,000	-5,277,000	57,645,000	16,590,000	-10,707,000	4,351,000	-26,260,000	-411,000	-121,257,000	10,401,000	18,974,000	-12,273,000	7,164,000	2,202,000
gain on escrow settlement
payments on line-of-credit																																-53,500,000	0	0	-6,000,000	0	0	-24,987,000	-91,513,000		-8,500,000	-1,500,000	-24,500,000			-6,000,000	-13,000,000
contingent consideration payments																		0	-3,300,000	-182,000	0
other investing activity
net cash from investing activities																			-7,120,000
net earnings, including non-controlling interest
change in operating assets and liabilities, net of acquisitions:
trade accounts payable and accrued expenses																												-1,876,000	2,592,000			3,361,000	6,401,000	-4,173,000	-563,000	-1,603,000	2,050,000	1,116,000	4,132,000	3,434,000	7,561,000	-1,655,000	-416,000	664,000	533,000	2,444,000	-1,487,000	793,000	1,569,000	-166,000	-828,000	458,000	-475,000	42,000	218,000	1,641,000	1,435,000	1,598,000
proceeds from sale and maturities of available-for-sale investments																				0	23,231,000			24,453,000	54,269,000
purchase of available-for-sale investments																																				-1,444,000	0											-17,463,000	-17,406,000	-44,867,000	-27,010,000	-23,613,000	-46,479,000	-21,501,000	-21,119,000	-124,007,000	-84,043,000	-34,311,000
other investing activities
other financing activities
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
other current assets																					1,922,000	-3,140,000	1,632,000		70,000	1,229,000	-2,549,000				-1,354,000
re-purchase of common stock
proceeds from long-term debt																															580,000,000
net increase in cash and cash equivalents																					20,610,000				45,924,000				9,675,000					48,994,000	-19,148,000		904,000	-10,653,000	5,352,000		3,261,000								25,201,000	14,546,000	-79,930,000		7,427,000	12,481,000	14,130,000	17,667,000	3,381,000	1,622,000
net decrease in cash and cash equivalents																							22,779,000				-995,000				-27,316,000												-5,690,000		13,479,000	-5,271,000	-220,329,000
contingent consideration payable
payment of contingent consideration
debt issuance costs																															-3,004,000
gain on investment
excess tax benefit from stock option exercises																																				112,000	97,000	52,000	253,000	-805,000	119,000	-11,000	131,000	-1,007,000	134,000	180,000	78,000			-36,000	-4,000	-6,000	-5,000	-63,000	-1,000	-51,000	-13,000	-7,000
payments of contingent consideration																																	8,800,000	0	-35,000,000
impairment of investment
accounts receivable																													-20,984,000
purchases of property and equipment																													-4,925,000				-3,508,000
borrowings under credit agreement																													0
payments on credit agreement																													-23,125,000
other financing																													0				-2,182,000	-355,000	-1,802,000
trade accounts payable, accrued expenses, and contract liabilities																															3,107,000
contingent consideration
purchase of equity investment
gain on sale of cyvek
contingent consideration and acd compensation, operating
contingent consideration and acd compensation, financing
contingent consideration, operating
other																																					208,000	-139,000	262,000	204,000	-433,000	178,000	26,000	492,000	-29,000	-73,000	68,000	168,000	108,000	192,000	124,000	426,000	125,000	105,000	107,000	-10,000	108,000	19,000
investment in non-consolidated company
contingent consideration, financing
proceeds from available-for-sale investments
purchases of available for sale investments																																							-6,836,000
payment on line-of-credit and other
gain on cyvek acquisition																																													0
net proceeds from maturities and purchases of available-for-sale investments
distributions from unconsolidated entities																																															446,000
net loss from equity method investees
purchase of common stock for stock bonus plans																																																				0	0	0	-573,000	-907,000	-907,000	-907,000
repurchase of common stock																																																								-21,283,000	-17,748,000	-10,675,000
proceeds from sales of available-for-sale investments																																																	9,030,000	21,645,000	12,700,000		9,830,000	10,337,000	6,200,000	53,931,000	39,085,000	10,195,000
payments on line of credit and other
impairment losses on investments
increase in other long-term assets																																																	-5,000	83,000	-138,000	-151,000	-168,000	-337,000	-87,000			-10,000,000
losses by equity method investees																																																					31,000	42,000	41,000	558,000	415,000	198,000
acquisition, net of cash acquired																																																		-100,000	-103,049,000
distribution from unconsolidated entity																																																		0	85,000					42,000	42,000
impairment loss on investments																																																								3,254,000
increase in other assets																																																								-489,000
trade, other accounts payable and accrued expenses
income taxes payable/receivable

Bio-Techne Corporation(NASDAQ:TECH)

Bio-Techne Corporation
(NASDAQ:TECH)